Androniki Bili, MD, MPH
Rheumatology
Accepting new patients
Sees patients age 18 and up
Penn Rheumatology Perelman
Schedule onlineCall 215-662-2454
Penn Medicine Provider

About me

  • Adjunct Assistant Professor of Medicine (Rheumatology)

Education and training

  • Medical School: Aristotle University of Thessaloniki
  • Residency: Long Island Jewish Medical Center
  • Residency: Rochester General Hospital
  • Fellowship: University of Rochester Medical Center

What my patients think about me

Average Rating

56 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

December 2025
dr. bili is very warm and caring. she never seems to get ruffled. she went back over many sets of blood tests to show my improvement in a few areas. she is a very good listener. this i have found is rare in many doctors. a few years ago a friend and i discovered that we were both seeing dr. bili. we both think she's wonderful.
December 2025
doc goes above and beyond to make sure you get treated.
November 2025
Dr. Bili has a good understanding of my condition and has a good idea of treatment.
November 2025
she's an excellent physician

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Bili is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Bili A, Dobson S, Quinones J, Phongsamart W, Oberdorfer P, Kosalaraksa P, Dagan R, Richmond P, Wilck M, Vallejos W, Nunn C, McFetridge R, Tamms G, Fu R, Lupinacci R, Musey L, Bickham K A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immunogenicity in healthy infants (PNEU-DIRECTION) , Vaccine: 2023

Russell K, Rupp RE, Morales-Ramirez JO, Diaz-Perez C, Andrews AP, Lee AW, Finn TS, Cox KS, Russell AF, Schaller MM, Martin JC, Hyatt DM, Gozlan-Kelner S, Bili A, Coller BG. A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-naïve and flavivirus-experienced healthy adults , Human Vaccines and Immunotherapeutics : 2022

Aletaha D, Bingham CO, Karpouzas GA, Takeuchi T, Thorne C, Bili A, Agarwal P, Hsu B, Rao R, Brown K, Tanaka Y Long-term safety and efficacy of sirukumab for patients with rheumatoid arthritis who previously received sirukumab in randomised controlled trials (SIRROUND-LTE) , RMD Open 2021 , 7: 2020,e001465

Schanberg LE, Ramanan AV, De Benedetti F, Beukelman T, Eakin GS, Del Gaizo V, Ringold S, Vesely R, Schrandt S, Jaki T, Bili A, Chung JB, De Bono S, Douglass W, Enejosa JV, Kanik KS, Knobe K, Kunder R, Leite-Schnell JC, Suehiro RM, Wong RL, Mieszkalski KL, Marrow LC, Siebenaler K, Fraulo E, Kimura Y. Toward Accelerated Authorization and Access to New Medicines for Juvenile Idiopathic Arthritis. Arthritis , Rheumatol , 71(12): 2019,1976-1984

Sharma T, Wasko MC, Tang X, Vedamurthy D, Yan X, Cote J, Bili A. Hydroxychloroquine use is Associated with Decreased Risk of Cardiovascular Events in Rheumatoid Arthritis Patients. , J Am Heart Assoc., 5(1): 2016,e002867

Schroeder LL, Tang X, Wasko MC, Bili A. Glucocorticoid use is associated with increased HDL in rheumatoid arthritis patients. , Rheumatol Int., 35(6): 2015,1059-67

Bili A, Tang X, Pranesh S, Bozaite R, Morris S, Antohe J, Kirchner HL. Wasko MC. TNF-α inhibitor use and decreased risk for incident coronary events in rheumatoid arthritis patients. , Arthritis Care Res (Hoboken), 66(3): 2014,355-63

Cote J, Harrington TH, Meadows A, Lin F, Bili A Fellow’s Forum Case Report: New Sarcoidosis Cases in Patients Treated with Tumor Necrosis Factor–Alpha Inhibitors , The Rheumatologist: 2013

Cote J, Bili A Aspirin use in rheumatoid arthritis patients with increased risk of cardiovascular disease. , ISRN Rheumatology, 2013(589807): 2013

Bili A, Morris SJ, Sartorius JA, Kirchner HL, Antohe JA, Dancea S, Wasko MCM TNF-α inhibitor use is not associated with lipid changes in patients with rheumatoid arthritis. , J Rheumatol, 39(5): 2012,946-948